CORE--CLINICAL INVESTIGATIONS SHARED RESOURCE

描述：(申请人的描述)临床医生的活动 以患者转诊为中心的调查共享资源 办公室。此资源提供给SAN的成员调查人员 安东尼奥癌症研究所支持适当的转诊和快速 完成同行评审、资助的临床研究项目和 由调查员发起的先导研究。 患者转诊办公室是患者访问的主要场所 癌症中心临床试验。患者转诊协调员接受 来自医生、患者和其他人的电话询问 临床试验的可用性。通过邮件联系的人也会被寻址 从这个办公室打来的电话。患者转诊协调员可以 通过电话评估初步患者资格，收集临床数据 供审查，并安排由SACI内科医生兼研究员进行评估。 自1997年1月1日以来，该办公室已受理电话1255个 关于获得临床试验或癌症的问题。这些电话可能很短， 单个联系人或多个联系人发起几个小时或对话 协调员和推荐人之间的多次后续呼叫 肿瘤学家、患者、方案调查人员和癌症中心人员。 患者转诊协调员配备为呼叫者提供向上- 关于所有治疗性临床研究的最新资格和治疗 在这个癌症中心进行的研究，包括所有合作小组 研究，NCI第一阶段合作协议研究，调查员发起 机构试点研究和制药公司赞助的研究 在SACI实验治疗计划下进行，以及 NSABP乳腺癌预防试验，跨组前列腺癌 SACI癌症的预防试验和转诊评估 预防和风险评估诊所，与 SACI癌症预防和健康促进以及乳腺癌计划。 患者转诊办公室已成为一个重要和核心的组成部分 我们的癌症中心与社区和其他人的互动 癌症治疗设施。该办公室提供了一个有效的机制 确保将临床试验与 患者的治疗需求。值得注意的是，患者转诊 协调员对医院临床调查项目的特殊价值 SACI是她在从以下方面获得深入信息方面的专业水平 呼叫者关于他们的治疗需求，呼叫者潜在的 参与SACI临床试验，制定切实可行的计划 来电者在我们的环境中或在另一种癌症环境中的进一步评估 中间。

Description: (Applicant's Description) The activities of the Clinical Investigations Shared Resource are centered around the Patient Referral Office. This resource is offered to member-investigators of the San Antonio Cancer Institute to support appropriate referral to and rapid completion of peer reviewed, funded clinical research projects and investigator-initiated pilot studies. The Patient Referral Office is the primary venue for patient access to cancer center clinical trials. The Patient Referral Coordinator accepts telephone inquiries from physicians, patients and others about the availability of clinical trials. Contacts by mail are also addressed through phone calls from this office. The Patient Referral Coordinator can assess preliminary patient eligibility by phone, assemble clinical data for review, and arrange an evaluation by a SACI physician-investigator. Since January 1, 1997, this office has accepted 1,255 telephone calls about access to clinical trials or cancer. These calls may be brief, single contacts or many initiate several hours or conversation and multiple follow-up calls between the coordinator and the referring oncologist, patient, protocol investigators and cancer center personnel. The Patient Referral Coordinator is equipped to provide callers with up- to-date eligibility and treatment about all therapeutic clinical research studies conducted at this cancer center, including all cooperative group studies, NCI Phase I Cooperative Agreement studies, investigator-initiated institutional pilot studies, and pharmaceutical company-sponsored studies conducted under the SACI Experimental Therapeutics Program, as well as the NSABP Breast Cancer Prevention Trial, the Intergroup Prostate Cancer Prevention Trial, and referrals for evaluation in the SACI Cancer Prevention and Risk Assessment Clinic related to studies conduced by the SACI Cancer Prevention and Health Promotion and Breast Cancer Programs. The Patient Referral Office has become an essential and central component of our cancer center's interactions with the community and with other cancer treatment facilities. The office provides an efficient mechanism for assuring the highest likelihood of matching a clinical trial with a patient's treatment needs. It is noteworthy that the Patient Referral Coordinator's special value to the clinical investigations programs of the SACI is her level of expertise in obtaining in-depth information from callers about their treatment needs, the caller's potential for participation in a SACI clinical trial, and developing realistic plans for the caller's further evaluation in our setting or that of another cancer center.